Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Cosmos Health Inc. COSM NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
12/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Cosmos Health Inc. (COSM) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.33. It has a SharesGrow Score of 11/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Valuation: COSM trades at a trailing Price-to-Earnings (P/E) of -0.5 (S&P 500 average ~25).

Financials: revenue is $54M, -0.8%/yr average growth. Net income is $16M (loss), growing at -31.7%/yr. Net profit margin is -29.7% (negative). Gross margin is 7.9% (-6.9 pp trend).

Balance sheet: total debt is $12M against $25M equity (Debt-to-Equity (D/E) ratio 0.48, conservative). Current ratio is 0.99 (tight liquidity). Debt-to-assets is 21.8%. Total assets: $54M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 33/100 (Fail), Moat 0/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

COSM SharesGrow Score Overview

19/100
SharesGrow Score
Weak fundamentals
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — COSM

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
COSM: -0.8%/yr revenue is, -31.7%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet COSM: Debt-to-Equity (D/E) ratio 0.48 (conservative), Current ratio is 0.99 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
COSM: Net profit margin is -29.7%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.28-1.32
Volume1.11M
Avg Volume (30D)763.34K
Market Cap$9.09M
Beta (1Y)4.46
Share Statistics
EPS (TTM)-1.17
Shares Outstanding$19.15M
IPO Date2010-07-23
Employees149
CEOGrigorios Siokas
Financial Highlights & Ratios
Revenue (TTM)$54.43M
Gross Profit$4.31M
EBITDA$-13.92M
Net Income$-16.18M
Operating Income$-15.54M
Total Cash$336.25K
Total Debt$11.82M
Net Debt$11.51M
Total Assets$54.31M
Price / Earnings (P/E)-0.3
Price / Sales (P/S)0.17
Analyst Forecast
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS2214133058

Price Chart

Track all markets on TradingView
COSM
Cosmos Health Inc. ↗  ·  NASDAQ Capital Marke
Healthcare • Drug Manufacturers - Specialty & Generic
0.28 52WK RANGE 1.32

People Also View

SGIOY
SGIOY
Shionogi & Co., Ltd.
$10.52
-1.31%
 CTLT
CTLT
Catalent, Inc.
$63.48
+0.00%
 TLRY
TLRY
Tilray Brands, Inc.
$6.91
+2.83%
 IRWD
IRWD
Ironwood Pharmaceuticals, Inc.
$4.04
+10.68%
 ALIM
ALIM
Alimera Sciences, Inc.
$5.54
-0.18%
 LFCR
LFCR
Lifecore Biomedical, Inc.
$5.20
+5.26%
 ADMP
ADMP
Adamis Pharmaceuticals Corporation
$0.78
+0.85%
 SBFM
SBFM
Sunshine Biopharma, Inc.
$0.97
-2.17%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message